Skip to Content

ECCO 2019: Direct and indirect costs of IBD in the biological era

Crohn’s disease (CD) and ulcerative colitis (UC) carries a high burden on healthcare resources. To date, no study has assessed the combined direct and indirect cost of inflammatory bowel disease (IBD) in a population-based setting. Click and hear the interesting result from a population-based inception cohort with 10 years of follow-up, here presenting by Bobby Zhao Sheng Lo.

Få adgang til artiklen

Hvis du er læge, sygeplejerske eller anden sundhedsprofessionel kan du få adgang til hele artiklen ved at oprette en profil på BestPractice Nordic.

Back to top